|
1
|
Park A, Rome S, Gantioque R. Jehovah's Witness Patients: Interventions for Successful Stem Cell Transplantation Without Blood Product Transfusions for Hematologic Malignancies. Clin J Oncol Nurs 2019; 23:364-369. [PMID: 31322623 DOI: 10.1188/19.cjon.364-369] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
BACKGROUND Jehovah's Witnesses are members of a religion that prohibits them from accepting blood product transfusions. This refusal makes them a particularly compelling population in the context of hematologic malignancies and stem cell transplantation, because blood product transfusions are a mainstay of supportive treatment. OBJECTIVES This article presents preventive and supportive measures allowing Jehovah's Witness patients the opportunity to receive a stem cell transplantation without blood product transfusions. METHODS A literature review was done that included evidence focusing on optimizing hematopoiesis, blood loss prevention, alterations in chemotherapy regimens, and implications for nursing practice. FINDINGS With proper preventive and supportive care measures, Jehovah's Witness patients can receive stem cell transplantations for hematologic malignancies without blood product transfusions.
Collapse
|
|
2
|
Perol L, Grignano E, Contejean A, Gastaud L, Legoff M, Franchi P, Deau-Fischer B, Willems L, Bouscary D, Tamburini J. High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah's Witnesses patients: a feasible option in the age of hematopoietic growth factors. Leuk Lymphoma 2019; 60:2324-2327. [PMID: 30773115 DOI: 10.1080/10428194.2019.1577414] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Affiliation(s)
- Louis Perol
- Hematology Department, Cochin Hospital , Paris , France.,Paris Descartes University , Paris , France
| | - Eric Grignano
- Hematology Department, Cochin Hospital , Paris , France.,Paris Descartes University , Paris , France
| | - Adrien Contejean
- Hematology Department, Cochin Hospital , Paris , France.,Paris Descartes University , Paris , France
| | - Lauris Gastaud
- Hematology Department, Antoine Lacassagne Cancer Center , Nice, France
| | - Marielle Legoff
- Hematology Department, Cochin Hospital , Paris , France.,Paris Descartes University , Paris , France
| | - Patricia Franchi
- Hematology Department, Cochin Hospital , Paris , France.,Paris Descartes University , Paris , France
| | - Bénédicte Deau-Fischer
- Hematology Department, Cochin Hospital , Paris , France.,Paris Descartes University , Paris , France
| | - Lise Willems
- Hematology Department, Cochin Hospital , Paris , France.,Paris Descartes University , Paris , France
| | - Didier Bouscary
- Hematology Department, Cochin Hospital , Paris , France.,Paris Descartes University , Paris , France
| | - Jerome Tamburini
- Hematology Department, Cochin Hospital , Paris , France.,Paris Descartes University , Paris , France
| |
Collapse
|